Sales decline 5.37% to Rs 193.58 crore
Net profit of Astrazeneca Pharma India declined 13.43% to Rs 18.63 crore in the quarter ended June 2020 as against Rs 21.52 crore during the previous quarter ended June 2019. Sales declined 5.37% to Rs 193.58 crore in the quarter ended June 2020 as against Rs 204.56 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales193.58204.56 -5 OPM %14.7517.39 -PBDT30.9438.27 -19 PBT26.3833.64 -22 NP18.6321.52 -13Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
